Skip to content
Lower risk Medical device recall · FDA · Published January 24, 2019

Maquet Axius Blower Mister Recall: Risk of CO2 Flow Delay During Surgery

Maquet recalls Axius Blower Mister (CB-1000) due to potential CO2 flow issues during off-pump coronary artery bypass surgery. Affected units have specific lot numbers; contact for remedy.

🇺🇸 FDA recall #Z-0983-2019Medical deviceMaquet ›
Take action

Contact the company

Recalling firmMaquet Cardiovascular, LLC45 Barbour Pond Dr · Wayne, NJ 07470-2094
✎ GovInfoNow plain-language explainer

Maquet is recalling the Axius Blower Mister device because it may not properly clear CO2 during certain heart surgeries, causing delays. This could affect surgical outcomes if the device fails to function correctly. Read more at govinfonow.com/recall/69087-maquet-axius-blower-mister-recall-risk-of-co2-flow-delay.

Source Summary by GovInfoNow · govinfonow.com/recall/69087-maquet-axius-blower-mister-recall-risk-of-co2-flow-delay · Updated August 20, 2026 · FDA enforcement record: FDA #Z-0983-2019

Cite this page

“Maquet Axius Blower Mister Recall: Risk of CO2 Flow Delay During Surgery.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69087-maquet-axius-blower-mister-recall-risk-of-co2-flow-delay. Based on FDA recall #Z-0983-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0983-2019%22&limit=1).

The FDA announced on Jan. 24, 2019, that Maquet Cardiovascular, LLC is recalling the AXIUS Blower Mister (Product Code CB-1000) due to a potential lack of carbon dioxide flow. This defect may cause procedural delays during off-pump coronary artery bypass surgery.

How to tell if you have it

  • Brand: Maquet
  • Product: AXIUS Blower Mister
  • Product Code/REF Number: CB-1000
  • Lot Numbers: 96255605, 96255607, 96255608, 96255609, 96255611
  • UDI: 20607567700745

The hazard

The recall addresses a potential lack of carbon dioxide (CO2) flow from the device. According to the FDA, this issue may result in a procedural delay during off-pump coronary artery bypass (OPCAB).

Context

GovInfoNow's records show Maquet Cardiovascular, LLC has had 25 other recalls since April 18, 2019. Recent brand issues include the June 2, 2026 Vasoview Hemopro 2 gamma sterilization issue and the Aug. 15, 2025 Heartstring III Proximal Seal System bleeding risk. Other recent recalls of similar products include the Maquet Flow-i Anesthesia Machines inadequate anesthesia delivery (June 24, 2026), the Erbe ERBECRYO 2 cryoprobe rupture risk (June 26, 2026), and the GE Healthcare Carestation power board ventilation disruption (Nov. 14, 2025).

How to tell if you have this one

Check for lot numbers 96255605, 96255607, 96255608, 96255609, or 96255611 on the device. The product code is CB-1000.

  • Brand
    Maquet
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Lot Number

    Look for lot numbers 96255605, 96255607, 96255608, 96255609, or 96255611 on the device.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution: US (Nationwide) and countries of: Australia, Belgium, Canada, Czech Republic, France, Germany, Korea, Netherlands, Russia, Spain, Switzerland, and United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

1. Firm started the recall: Jan 24, 201912. FDA classified it Class II: Mar 7, 201923. Published in FDA’s Enforcement Report: Mar 13, 201934. FDA terminated the recall: Jul 13, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0983-2019 (January 24, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0983-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA